This study aimed to quantify 24 h body core temperature (BcT°) and sleep-wake cycle rhythm alterations in craniopharyngioma (CP) patients and to identify markers related to the postsurgical outcomes. Ten consecutive CP patients underwent neuroradiological, endocrinological and ophthalmological evaluations, 24 h BcT° and sleep-wake cycle recordings before and after endoscopic endonasal surgery. The sample included four women and six men. Nocturnal sleep efficiency was pathologically reduced in eight patients before surgery. Seven out of ten patients presented one to three daytime naps. 24 h BcT° rhythm was pathological in six out of ten cases. Post-surgery sleep efficiency normalized in four out of eight patients, whereas nine out of ten ...
Craniopharyngiomas are rare solid or mixed solid and cystic tumors that arise from Rathke’s pouch re...
Anesthesia during asleep-awake craniotomy should provide adequate analgesia and sedation whereas per...
Hypothalamic obesity (HO) is a major concern in patients treated for craniopharyngioma (CP). The inf...
This study aimed to quantify 24 h body core temperature (BcT°) and sleep-wake cycle rhythm alterati...
Objective One of the more serious risks in the treatment of third ventricle craniopharyngiomas is re...
Sleep disorders (SDs) represent an important issue in patients with craniopharyngioma (CP). Nearly 7...
Objective: Patients treated for nonfunctioning pituitary macroadenomas (NFMAs) have fatigue and alte...
Childhood craniopharyngiomas are rare embryogenic malformations of the sellar region, presumably der...
Aim: To investigate the potential association among Craniopharyngioma (CP), chronotypes and metaboli...
Objective: Although craniopharyngiomas are benign pathologies, they have surgical challenges due to ...
Craniopharyngioma (CP) patients suffer from high rates of morbidity and mortality. The aim of this s...
Craniopharyngioma (CP) is a histologically benign tumor with high mortality and morbidity. Although ...
Objective: Despite excellent survival prognosis, children treated for craniopharyngioma experience s...
Significant disruptions in sleep–wake cycles have been found in advanced cancer patients in prior re...
Craniopharyngiomas are locally aggressive tumors which typically are focused in the sellar and supra...
Craniopharyngiomas are rare solid or mixed solid and cystic tumors that arise from Rathke’s pouch re...
Anesthesia during asleep-awake craniotomy should provide adequate analgesia and sedation whereas per...
Hypothalamic obesity (HO) is a major concern in patients treated for craniopharyngioma (CP). The inf...
This study aimed to quantify 24 h body core temperature (BcT°) and sleep-wake cycle rhythm alterati...
Objective One of the more serious risks in the treatment of third ventricle craniopharyngiomas is re...
Sleep disorders (SDs) represent an important issue in patients with craniopharyngioma (CP). Nearly 7...
Objective: Patients treated for nonfunctioning pituitary macroadenomas (NFMAs) have fatigue and alte...
Childhood craniopharyngiomas are rare embryogenic malformations of the sellar region, presumably der...
Aim: To investigate the potential association among Craniopharyngioma (CP), chronotypes and metaboli...
Objective: Although craniopharyngiomas are benign pathologies, they have surgical challenges due to ...
Craniopharyngioma (CP) patients suffer from high rates of morbidity and mortality. The aim of this s...
Craniopharyngioma (CP) is a histologically benign tumor with high mortality and morbidity. Although ...
Objective: Despite excellent survival prognosis, children treated for craniopharyngioma experience s...
Significant disruptions in sleep–wake cycles have been found in advanced cancer patients in prior re...
Craniopharyngiomas are locally aggressive tumors which typically are focused in the sellar and supra...
Craniopharyngiomas are rare solid or mixed solid and cystic tumors that arise from Rathke’s pouch re...
Anesthesia during asleep-awake craniotomy should provide adequate analgesia and sedation whereas per...
Hypothalamic obesity (HO) is a major concern in patients treated for craniopharyngioma (CP). The inf...